Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment.
Vinetz
Joseph M
JM
Division of Infectious Diseases, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California 92093-0741, USA. jvinetz@ucsd.edu
D000962:Antimalarials; D004351:Drug Resistance; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D016780:Malaria, Vivax / Q000188:drug therapy*; D015767:Mefloquine
D000962:Antimalarials; D015767:Mefloquine